Serum ferritin and primary lung cancer

Zhongqing Chen; Bo Zhu; Chao Ou; Yuxuan Li

doi:10.18632/oncotarget.21518

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Serum ferritin and primary lung cancer

Zhongqing Chen, Bo Zhu _, Chao Ou and Yuxuan Li

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:92643-92651. https://doi.org/10.18632/oncotarget.21518

Metrics: PDF 1423 views | HTML 3250 views | ?

Abstract

Zhongqing Chen1, Bo Zhu1, Chao Ou2 and Yuxuan Li3

1Department of Clinical Laboratory, Guangxi Medical University Affiliated Tumor Hospital, Nanning 530021, Guangxi Province, P.R. China

2Experimental Research Department, Guangxi Medical University Affiliated Tumor Hospital, Nanning 530021, Guangxi Province, P.R. China

3Department of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Nanning 530021, Guangxi Province, P.R. China

Correspondence to:

Bo Zhu, email: [email protected]

Keywords: primary lung cancer, Serum ferritin, Hemoglobin, Transferrin, Menopause

Abbreviations: serum ferritin (SF); tumor-nodes-metastasis (TNM); hemoglobin (Hb); transferrin (TRF)

Received: July 28, 2017 Accepted: September 04, 2017 Published: October 04, 2017

ABSTRACT

Existing research yields conflicting results regarding the relation between iron deficiency and high serum ferritin (SF) levels in primary lung cancer patients. We investigated the concentrations of SF, hemoglobin (Hb) and transferrin (TRF) in 569 male primary lung cancer patients and 252 female primary lung cancer patients. We grouped the subjects according to gender, smoking status, menopausal status, pathological type, stage, and TNM stage. The levels of SF and TRF were correlated with T stage in male patients (p<0.01). The levels of SF and TRF were correlated with menopausal status in female patients (p<0.01). Hb was correlated with smoking status, pathological type, stage, and TNM stages in male patients(p<0.01), but in female patients, Hb was not correlated with these grouping factors(p>0.05). The levels of SF may be regulated by different mechanisms and may be of different physiological significance in different populations.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21518

Publication Alerts

Oncoscience

Post-Publication Promotion

Research Papers:

Serum ferritin and primary lung cancer

Abstract